The problem is no more whether retatrutide works -- the data is compelling -- but how long the regulatory route takes and if the acceptance lands with a safety profile that insurers and clients can operate with.Ladies who're pregnant, attempting to get Expecting, or breastfeeding, since there’s not more than enough safety informationThe 4mg upkee